Literature DB >> 8394446

Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.

A Roulston1, P Beauparlant, N Rice, J Hiscott.   

Abstract

The relationship between human immunodeficiency virus type 1 (HIV-1) infection and the induction of NF-kappa B binding activity was examined in a myeloid cell model of HIV-1 infection derived from the PLB-985 cell line. Chronic infection of PLB-985 cells led to increased monocyte-specific surface marker expression, increased c-fms gene transcription, and morphological alterations consistent with differentiation along the monocytic pathway. PLB-IIIB cells displayed a constitutive NF-kappa B-like binding activity that was distinct from that induced by tumor necrosis factor alpha or phorbol 12-myristate 13-acetate treatment of the parental PLB-985 cell line. This unique DNA binding activity consisted of proteins of 70, 90, and 100 kDa with a high degree of binding specificity for the NF-kappa B site within the PRDII domain of beta interferon. In this report, we characterize the nature of these proteins and demonstrate that binding of these proteins is also induced following Sendai paramyxovirus infection. The 70-kDa protein corresponds to the NF-kappa B RelA (p65) subunit, which is activated in response to an acute paramyxovirus infection or a chronic HIV-1 infection. Virus infection does not appear to alter the amount of RelA (p65) or NFKB1 (p50) but rather affects the capacity of I kappa B alpha to sequester RelA (p65), therefore leading to constitutive levels of RelA DNA binding activity and to increased levels of NF-kappa B-dependent gene activity. The virally induced 90- to 100-kDa proteins have a distinct binding specificity for the PRDII domain and an AT-rich sequence but do not cross-react with NF-kappa B subunit-specific antisera directed against NFKB1 (p105 or p50), NFKB2 (p100 or p52), RelA (p65), or c-rel. DNA binding of the 90- to 100-kDa proteins was not inhibited by recombinant I kappa B alpha/MAD-3 and was resistant to tryptic digestion, suggesting that these proteins may not be NF-kappa B related. Transient cotransfection experiments demonstrated that RelA and NFKB1 expression maximally stimulated HIV-1 LTR- and NF-kappa B-dependent reporter genes; differences in NF-kappa B-like binding activity were also reflected in higher constitutive levels of NF-kappa B-regulated gene expression in HIV-1-infected myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394446      PMCID: PMC237921     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  The Rel family: models for transcriptional regulation and oncogenic transformation.

Authors:  H R Bose
Journal:  Biochim Biophys Acta       Date:  1992-09-14

Review 2.  NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.

Authors:  V Blank; P Kourilsky; A Israël
Journal:  Trends Biochem Sci       Date:  1992-04       Impact factor: 13.807

3.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.

Authors:  T Fujita; G P Nolan; S Ghosh; D Baltimore
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

4.  Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

Authors:  J E Merrill; Y Koyanagi; I S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

6.  Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.

Authors:  J Inoue; L D Kerr; D Rashid; N Davis; H R Bose; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

Authors:  A A Beg; S M Ruben; R I Scheinman; S Haskill; C A Rosen; A S Baldwin
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

8.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.

Authors:  P A Baeuerle; D Baltimore
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

9.  NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells.

Authors:  C V Paya; R M Ten; C Bessia; J Alcami; R T Hay; J L Virelizier
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.

Authors:  F G Wulczyn; M Naumann; C Scheidereit
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

View more
  19 in total

1.  Successful outcome in a HIV infected child presenting with Pre-B Acute Lymphoblastic Leukemia.

Authors:  Moumita Ghosh; Mukut Banerjee; Swapna Chakraborty; Subhasish Bhattacharyya
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

2.  Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages.

Authors:  S R Lewin; P Lambert; N J Deacon; J Mills; S M Crowe
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth.

Authors:  B K Chen; M B Feinberg; D Baltimore
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.

Authors:  S P Lim; A Garzino-Demo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Caveolin-1 suppresses human immunodeficiency virus-1 replication by inhibiting acetylation of NF-κB.

Authors:  Glenn E Simmons; Harry E Taylor; James E K Hildreth
Journal:  Virology       Date:  2012-06-28       Impact factor: 3.616

6.  NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages.

Authors:  S Asin; G D Bren; E M Carmona; N J Solan; C V Paya
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors.

Authors:  E Garoufalis; I Kwan; R Lin; A Mustafa; N Pepin; A Roulston; J Lacoste; J Hiscott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 8.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

9.  The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.

Authors:  L Folgueira; A Algeciras; W S MacMorran; G D Bren; C V Paya
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.